Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib as a potential treatment for sclerodermatous chronic graft-vs-host disease.

× No keyword cloud information.

7 in total

Review 1. Cutaneous graft-versus-host disease--clinical considerations and management.

Authors: Peggy A Wu; Edward W Cowen
Journal: Curr Probl Dermatol Date: 2012-02-17

Review 2. The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors: Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal: J Dermatol Sci Date: 2010-07-03 Impact factor: 4.563

Review 3. Immunotherapy of systemic sclerosis.

Authors: Rebecca Manno; Francesco Boin
Journal: Immunotherapy Date: 2010-11 Impact factor: 4.196

4. Imatinib mesylate as salvage therapy for refractory sclerotic chronic graft-versus-host disease.

Authors: Leonardo Magro; Mohamad Mohty; Benoit Catteau; Valérie Coiteux; Patrice Chevallier; Louis Terriou; Jean-Pierre Jouet; Ibrahim Yakoub-Agha
Journal: Blood Date: 2009-03-16 Impact factor: 22.113

Review 5. Transforming growth factor beta as a therapeutic target in systemic sclerosis.

Authors: John Varga; Boris Pasche
Journal: Nat Rev Rheumatol Date: 2009-04 Impact factor: 20.543

Review 6. Cutaneous graft-versus-host disease after hematopoietic stem cell transplant - a review.

Authors: Cesar Daniel Villarreal Villarreal; Julio Cesar Salas Alanis; Jose Carlos Jaime Pérez; Jorge Ocampo Candiani
Journal: An Bras Dermatol Date: 2016 May-Jun Impact factor: 1.896

7. Imatinib and dasatinib as salvage therapy for sclerotic chronic graft-vs-host disease.

Authors: Isabel Sánchez-Ortega; Rocío Parody; Octavio Servitje; Cristina Muniesa; Montserrat Arnan; Beatriz Patino; Anna Sureda; Rafael F Duarte
Journal: Croat Med J Date: 2016-06-30 Impact factor: 1.351

7 in total